A110
メディスリム（４粒）
株式会社東洋新薬販売休止中
加工食品(錠剤、カプセル剤等)
Category
Notif. Date
2015-09-01
Planned Sale Date
Functional Claim
本品には、葛の花由来イソフラボン（テクトリゲニン類として）が含まれるので、内臓脂肪（おなかの脂肪）を減らすのを助ける機能があります。
Functional Ingredient
Content
Functional Claim
本品には、葛の花由来イソフラボン（テクトリゲニン類として）が含まれるので、内臓脂肪（おなかの脂肪）を減らすのを助ける機能があります。
AI Summary
Automatically generated from notification documents
This product contains kudzu flower-derived isoflavonoids (as tectrigening group) and has been reported to help reduce visceral fat, especially abdominal fat, when consumed alongside diet and exercise.
Key Features
[
"
K
u
d
z
u
F
l
o
w
e
r
I
s
o
f
l
a
v
o
n
o
i
d
s
"
,
"
V
i
s
c
e
r
a
l
F
a
t
R
e
d
u
c
t
i
o
n
S
u
p
p
o
r
t
"
,
"
E
a
s
y
4
C
a
p
s
u
l
e
s
D
a
i
l
y
"
]
Adults concerned about visceral fat, especially abdominal fat.
Recommended ProductsPR
広告: A8.net
Notification Documents
| Product Name | メディスリム（４粒） |
| Category | |
| Food Classification | 加工食品(錠剤、カプセル剤等) |
| Functional Ingredient Name | 葛の花由来イソフラボン（テクトリゲニン類として） |
| Functional ingredient is an extract | No |
| Functional Claim | 本品には、葛の花由来イソフラボン（テクトリゲニン類として）が含まれるので、内臓脂肪（おなかの脂肪）を減らすのを助ける機能があります。 |
| Consumer Affairs Department Contact | |
| Information Disclosure Website URL |
| (1) Precautions for Intake | |
| (2) Safety Evaluation Method | |
| (3) Notifier's Safety Evaluation |
| Details |
| (1) Functionality Evaluation Method | |
| (2) Notifier's Functionality Evaluation |
| Reason for not classifying as tablet/capsule food | |
| Primary Target Audience | |
| Planned Sales Start Date | |
| Change History (before Mar 31, 2025) | |
| Change History (from Apr 1, 2025) | |
| Before/After Comparison Table | |
| Before/After Comparison Table (attachments) | |
| If re-notification | No |
| Existing Notification Number | |
| Reason for Maintaining Identity | |
| Post-notification Sales Status | 販売休止中 |
| Reason for Notification Withdrawal |
| Month of Last Self-Inspection Report |